Umlaufvermögen Veränderung Datum
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
Cara Therapeutics USD 31.54M 6.9M 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
J&J USD 59.17B 3.55B 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 42.82B 76M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03